• Skin
    Dermal Delivery

    • MedPharm is the world’s leading contract development organisation for topical products.
    • MedPharm is at the leading edge of developing ex vivo penetration and disease models for optimising formulation design and target engagement against established and customer specific biochemical pathways.
    • MedPharm has an unrivalled reputation for creation of optimally effective, safe and aesthetically elegant dermatological formulations.
    • MedPharm has direct expertise in developing a wide range of semi-solid dosage forms including creams, gels, sprays, foams, ointments, lotions, mousses and lacquers.
    • MedPharm’s expertise extends to developing transdermal patches across a range of designs from drug in adhesive to multi-layer.
    • MedPharm expertise has supported clients directly to get biowaivers for generic applications.
    • MedPharm has developed customer specific models to support claims associated with OTC products.
    • MedPharm has its own formulation technology available to help optimise customer’s products performance.

  • Nails
    Ungual and transungual delivery

    • MedPharm is the world’s leading contract development organisation for nail treatment products.
    • MedPharm has aided development of all the major brands on the US and European market.
    • MedPharm has unique validated proprietary models for measuring the permeation, penetration and efficacy of customer’s products into and across the nail.
    • MedPharm has used its development and disease activity data and expertise on formulations for nails to support clients to obtain biowaivers from regulatory authorities eliminating the requirement for clinical testing.
    • MedPharm has direct expertise in developing a wide range of formulations for treating nails including creams, gels, sprays, lotions, and lacquers.

  • Eye
    Ocular Delivery

    • MedPharm has developed specific proprietary models for measuring trans-corneal penetration.
    • MedPharm has direct expertise in developing commercial topical, intravitreal (intra-ocular) and trans-scleral (peri-ocular) products for both immediate and controlled release.
    • MedPharm has unique performance models available using either human or porcine cornea.
    • MedPharm has developed ocular delivery formulations currently marketed in the US and Europe.

  • Airways
    Lung Delivery

    • MedPharm has developed numerous respiratory products currently marketed in the US and Europe.
    • MedPharm can develop specific proprietary models for measuring lung tissue penetration.
    • MedPharm are experts at aerosol/MDI formulation.
    • MedPharm offers our clients support and advice on the most appropriate device for their product matching formulation design to product design.
    • MedPharm can use its rigorous procedures for optimal nebuliser design during early stage development.

    Nasal Delivery

    • MedPharm has developed numerous nasal products for local and systemic delivery currently marketed in the US and Europe.
    • MedPharm has developed specific proprietary models for measuring nasal drug delivery (including bacteriophages), mucoadhesion and infection models for bacterial de-colonisation (e.g. MRSA), as well as assessing novel systems for anti-abuse.
    • MedPharm offers client support and advice on the most appropriate device for their product matching formulation design to product design.

  • Mucosal Membrane
    Oromucosal, Nasal, Rectal and Vaginal delivery

    • MedPharm develops bespoke performance models for clients using relevant tissue source to support their products’ clinical efficacy and extend marketing claims.
    • MedPharm has direct expertise in developing a wide range of formulations optimised for mucosal membrane treatment including creams, gels, ointments, suppositories, foams, sprays, lotions, lozenges and films.
    • MedPharm navigates clients through the optimal regulatory and formulation strategy in these highly niche markets.

  • Ear
    Otic Delivery

    • MedPharm develops bespoke performance models for clients using otic tissue in the most relevant ex-vivo model to support their products’ development.
    • MedPharm has extensive experience developing drops and foams, both of which are effective formulations for treating the ear canal.